Mirus Bio
Edward Dellarocca serves as General Counsel at Mirus Bio, a company specializing in transfection products for the biopharmaceutical and research sectors since August 2022. Prior to this role, Edward held several legal positions including Senior Counsel at StockX and Counsel at Experian Health. Additional experience includes serving as Corporate Counsel at Amphastar Pharmaceuticals, Inc., and Associate Counsel II at Gilead Sciences. Edward holds a Juris Doctor degree from Whittier Law School, graduating magna cum laude, and both a Master of Arts and a Bachelor of Arts degree, each earned summa cum laude, from California State University, Fullerton.
This person is not in any teams
This person is not in any offices
Mirus Bio
1 followers
Mirus Bio Corporation, a life science company, discovers, develops, and commercializes nucleic acid based technologies and products. It provides transfection reagents, electroporation kits and solutions, DNA and RNA labeling reagents, in vivo delivery products, and accessories. The company offers its products through distributors in Argentina,Australia, Austria, Belgium, Bangladesh, Canada, Chile, the People's Republic of China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Japan, Korea, Malaysia, the Netherlands, New Zealand, Norway, the Philippines, Portugal, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, the United Kingdom, the United States, and Vietnam. Mirus Bio Corporation was formerly known as Mirus Corporation. The company was founded in 1995 and is based in Madison, Wisconsin. As of September 30, 2008, Mirus Bio Corporation operates as a subsidiary of Roche Holding AG.